Abstract: A method for differentiating mesenchymal stem cells of bone marrow into neural cells comprises culturing the mesenchymal stem cells in a medium containing epidermal growth factor(EGF), basic fibroblast growth factor(bFGF) and hepatocyte growth factor(HGF), and the neural cells produced thereby can be employed for the treatment of a neural disease.
Type:
Grant
Filed:
April 19, 2002
Date of Patent:
June 12, 2007
Assignees:
FCB-Pharmicell Co., Ltd., LifeCord International Co., Ltd.